✦ LIBER ✦

W1181 Long-Term Efficacy and Safety of Maintenance Infliximab for the Treatment of Moderate-to-Severe Pediatric Crohn's Disease: Results from the Reach Study

✍ Scribed by Hyams, Jeffrey S.; Blank, Marion; Johanns, Jewel; Crandall, Wallace; Kugathasan, Subra; Griffiths, Anne M.; Heuschkel, Robert; Markowitz, James; Cohen, Stanley A.; Winter, Harland S.; Veereman, Gigi; Ferry, George D.; Walters, Thomas D.; Baldassano, Robert

Book ID: 122628948
Publisher: Elsevier Science
Year: 2009
Tongue: English
Weight: 140 KB
Volume: 136
Category: Article
ISSN: 0016-5085
DOI: 10.1016/S0016-5085(09)63094-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

P037 LONG-TERM EFFICACY AND SAFETY OF MA

P037 LONG-TERM EFFICACY AND SAFETY OF MAINTENANCE INFLIXIMAB THERAPY FOR THE TREATMENT OF MODERATE-TO-SEVERE PEDIATRIC CROHN'S DISEASE: RESULTS FROM THE REACH STUDY

✍ G. Veereman-Wauters; R. Baldassano; M. Blank; W. Crandall; A. Griffiths; R. Heus 📂 Article 📅 2009 🏛 Oxford University Press ⚖ 50 KB

Safety and efficacy of maintenance infli

Safety and efficacy of maintenance infliximab therapy for moderate-to-severe Crohn’s disease in children: REACH open-label extension

✍ Hyams, Jeffrey; Walters, Thomas D.; Crandall, Wallace; Kugathasan, Subra; Griffi 📂 Article 📅 2011 🏛 Informa plc 🌐 English ⚖ 296 KB

Induction and Maintenance Infliximab The

Induction and Maintenance Infliximab Therapy for the Treatment of Moderate-to-Severe Crohn’s Disease in Children

✍ Jeffrey Hyams; Wallace Crandall; Subra Kugathasan; Anne Griffiths; Allan Olson; 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 576 KB

Long-term safety and efficacy of memanti

Long-term safety and efficacy of memantine treatment in moderate to severe Alzheimer’s disease: Results from a three-year trial

📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 50 KB

Long-term efficacy and safety of mainten

Long-term efficacy and safety of maintenance versus intermittent infliximab therapy for moderate to severe plaque-type psoriasis: The RESTORE2 trial

📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 47 KB

W1092 Maintenance of Long-Term Remission

W1092 Maintenance of Long-Term Remission in Patients with Moderately to Severely Active Crohn's Disease Treated for 3 Years with Adalimumab: Results from the Open-Label ADHERE Study

✍ Rutgeerts, Paul; Colombel, Jean-Frederic; Sandborn, William J.; Rutgeerts, Paul 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 99 KB